Ambulatory Care

Milliman's Ambulatory Care product enables access to easy-to-use evidence-based criteria for Imaging, Diagnostic Testing, Rehabilitation Services, Ambulatory Surgery, Injectables, Referrals and Transplantation. Users can quickly find the authorisation criteria they need, as well as over 60 Optimum Treatment Guidelines for comprehensive background, scope, diagnosis, and treatment information.

• Emerging Technologies: The latest research is incorporated, including descriptions of established or proposed criteria, and results of published trials. The latest biotechnology drugs are addressed, as well as emerging technologies like radiofrequency saphenous vein ablation, surgeries for obstructive sleep apnea and artificial vertebral disks.
• Imaging: Among the most widely- used and effective tools for this setting, these criteria can be accessed by CCSD codes, diagnosis, technology or body region. This section delivers precise, actionable indications for imaging tests, including PET, CT, CT angiography, MRI, MR angiography, nuclear medicine, ultrasound and catheter angiography.
• Injectables and Other Pharmacologic Treatments: Over 40 guidelines provide criteria or evidence summaries for pharmacologic agents, including biologics. These include intravenous immunoglobulins, growth hormone, botulinum toxin, and erythropoietin.
• Evidence-based Methodology: The full-time staff producing the Care Guidelines uses international evidencebased resources. Clinician editors review thousands of articles during guideline development, with all applicable evidence being referenced within the product and abstracts made available where possible.

This product is available in an International version.